OptiZ: Real World Evidence Study

Not yet recruitingOBSERVATIONAL
Enrollment

113

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

August 1, 2026

Study Completion Date

October 1, 2026

Conditions
Hypertension
Interventions
DRUG

Zestril

N/A, this is an observational study.

Trial Locations (1)

NR3 3DL

Oak Street Medical Practice, Norwich

Sponsors
All Listed Sponsors
lead

Closed Loop Medicine

INDUSTRY

NCT06745726 - OptiZ: Real World Evidence Study | Biotech Hunter | Biotech Hunter